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Previewsprotect against severe disease. This is
consistent with the finding that recombi-
nant IFN-a administration early in PbA
infection reduced parasitemia and pro-
tected against ECM in a IFN-g-dependent
manner (Vigario et al., 2007). A beneficial
effect of type I IFNs was also suggested
by higher plasma IFN-a levels in African
children with mild malaria compared to
those with hyperparasitemia or severe
malarial anemia (Luty et al., 2000). The
heterogeneity and complexity of human
severe malaria necessitate examining
the role of type I IFNs in diverse patient
populations and in multiple murine
models representing different aspects of
human disease. However, the present
findings do caution against administration
of type I IFNs as adjunctive therapy for
CM, especially because patients typically
present with advanced pathology.
In summary, Sharma et al. (2011)
identify a unique cytosolic DNA sensing
pathway and considerably expand our
knowledge of the induction and role oftype I IFNs in malaria infection. The pres-
ence of AT-rich motifs in the genomes of
other protozoa, bacteria, and humans
suggests that these motifs could con-
tribute to the pathogenesis of other
severe infectious syndromes. In the case
of extracellular DNA sources, it is in-
triguing to consider that other crystals
(e.g., urate) may move these motifs into
the cytosol for innate sensing. This pro-
posed mechanism, if confirmed, may
have relevance for the development of
DNA-based vaccine adjuvants.REFERENCES
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In the current issue of Immunity, Martı´nez-Martı´n et al. (2011) describe the central supramolecular activation
cluster (cSMAC) as a site of clathrin-independent T cell receptor (TCR) internalization and trogocytosis.
Further, they identify small Rho GTPases TC21 and RhoG as key mediators of these processes.Cell-to-cell communication is essential for
the orchestration of the immune system
and its responses. Although immune cells
normally communicate through either
soluble or membrane-bound mediators,
new types of cellular interchange have
been described, including trogocytosis,
exosome secretion, and nanotube forma-
tion. The term trogocytosis (from Greek
trogo-, nibble) was originally coined to
describe the intercellular transfer of
membrane patches from an antigen-pre-senting cell (APC) to a lymphocyte (Joly
and Hudrisier, 2003). This is in strong
contrast to phagocytosis, the process of
engulfing whole pathogens and death
cell fragments by phagocytes.
The first evidence of trogocytosis was
the transfer of major histocompatibility
complex class II (MHCII) glycoproteins
from B to T cells (Cone et al., 1972). Since
then, trogocytotic activity has been re-
ported for T, B, natural killer (NK), and
dendritic cells and is well documentedin vitro and in vivo. Trogocytosis can be
distinguished from other mechanisms of
intercellular transfer because it requires
close cell-cell contact, is quick (within
minutes), and involves transfer of intact
proteins. Previous studies focused on the
cell types involvedand themolecules trans-
ferred, but the molecular mechanism that
underpins this phenomenon has remained
largely unknown. Trogocytosis is an active
process in T and NK cells, requiring both
receptor signaling and actin cytoskeleton, August 26, 2011 ª2011 Elsevier Inc. 151
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Figure 1. TCR Internalization and Trogocytosis in T Cells
Constitutive TCR turnover occurs in resting cells. Upon stimulation, TCR nanoclusters aggregate to
signaling-active microclusters that can be internalized in the pSMAC in a clathrin-dependent manner.
Once the microclusters have reached the cSMAC, patches of the APC containing the pMHC molecules
are trogocytosed with a TC21- and RhoG-dependent mechanism. Trogocytosed membrane proteins
from the APC can be re-expressed on the T cell.
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Previewsremodeling. In this issue of Immunity, the
group of Balbino Alarco´n provides new
insights into the molecular mechanism
that drives T cell antigen receptor (TCR)-
mediated trogocytosis by identifying the
small GTPases TC21 and RhoG as key
players (Martı´nez-Martı´n et al., 2011).
On resting T cells, the TCR coexists in
monomeric and nanoclustered forms
(Schamel et al., 2005). The amount of
TCR expressed on the cell surface is
tightly controlled by the rates of TCR
synthesis, constitutive clathrin-mediated
TCR internalization, recycling and degra-
dation (Figure 1). Once the T cell is stimu-
lated by antigenic peptides presented on
MHC (pMHC), the TCRs aggregate to
form microclusters. These pMHC-in-
duced microclusters contain phosphory-
lated TCRs that initiate activation of the
cell. Subsequently, themicroclusters coa-
lesce to form the central supramolecular
activation cluster (cSMAC) surrounded
by the peripheral SMAC (pSMAC), to-
gether forming an immune synapse. The
functional significance of the cSMAC has
been the subject of recent controversy.
Originally, it hadbeenproposed that accu-
mulation of engaged receptors and sig-
naling molecules in the cSMAC boosts
T cell activation. However, observations
that the cSMAC forms after the peak
of protein tyrosine phosphorylation has
been reached and is enriched in ubiquitin
ligases and ubiquitinylated proteins sug-
gested a role in TCR internalization and
degradation, and thus, in the termination
of signaling. Another layer of complexity152 Immunity 35, August 26, 2011 ª2011 Elswas added when analyzing ligands of
different qualities, given that the cSMAC
canenhance stimulation byweak agonists
(Cemerski et al., 2008). TCRstimulation by
pMHC leads to TCR downmodulation,
mainly by increasing TCR degradation,
because clathrin-mediated TCR endocy-
tosis is unchanged (Liu et al., 2000). How-
ever, intense TCR stimulation leads to
marginal acceleration of TCR internaliza-
tion by a second, clathrin-independent
pathway (Monjas, 2004). Yet, detailed
insight into when and where clathrin-
dependent or -independent internalization
occurs is still missing.
In the present article, Martı´nez-Martı´n
et al. identify the cSMAC as the site of
clathrin-independent TCR internalization
and report that together with the inter-
nalized TCR, membrane patches and
pMHC complexes from the APC are
trogocytosed.
Using time-lapse confocal videomicro-
scopy and primary T cells derived from
genetically ablatedmice, they have shown
that TCR internalization from the cSMAC
is dependent on the small GTPases
TC21 and RhoG. TC21 is constitutively
associated with the TCR and co-translo-
cates with the TCR to the cSMAC upon
T cell activation (Delgado et al., 2009).
Expression of either inactive or constitu-
tively active TC21 mutants inhibited TCR
internalization from the cSMAC, indicating
that conversion between the GDP- and
GTP-bound forms of TC21 is crucial for
this process. Moreover, TC21 and the
TCR colocalized in clathrin-deficient intra-evier Inc.cellular vesicles, and shRNA-mediated
silencing of clathrin did not affect TCR
and TC21 cointernalization. The authors
also have shown by electron microscopy
that, in contrast to the pSMAC, the
cSMAC is devoid of clathrin-coated pits.
Altogether, the authors propose a model
in which triggered TCRs are internalized
at the cSMAC by a TC21-dependent
but clathrin-independent mechanism. In
contrast, homeostatic clathrin-mediated
internalization might take place in the
pSMAC.
Additionally, RhoG was identified as a
player in TC21-dependent TCR internali-
zation. Like TC21, RhoG must cycle be-
tween active and inactive conformations
to promote TCR internalization from the
cSMAC. Because RhoG was first de-
scribed in the phagocytosis of apoptotic
bodies (Henson, 2005), the authors inves-
tigated the capability of T cells to phago-
cytose anti-TCR-coupled latex beads. It
was surprising that primary T cells were
able to phagocytose beads that were as
big as themselves, which they accommo-
dated through massive reorganization of
their cytoplasm and plasma membrane.
TCR-driven phagocytosis of beads was
impaired in T lymphocytes derived from
TC21- or RhoG-deficient mice when
compared to wild-type controls. In stimu-
lated T cells from TC21- and RhoG-defi-
cient mice, total downregulation of the
TCR was only slightly affected, suggest-
ing that clathrin-mediated internalization
was prominent. In contrast, acquisition
of membrane patches and MHC mole-
cules by trogocytosis was greatly de-
creased in CD4+ and CD8+ T cells.
Further, acquisition of membrane patches
and TCR-triggered phagocytosis were
actin dependent and probably equivalent
phenomena.
Using pharmacological inhibitors,
Martı´nez-Martı´n et al. showed that inacti-
vation of phosphatidyl inositol-3 kinase
(PI3K) reduced the phagocytosis of beads
as well as membrane acquisition by
trogocytosis. Furthermore, PI3K inhibitors
blocked RhoG-GTP formation without
affecting TC21 activation. This led the
authors to propose a novel signaling path-
way in which TC21, which directly binds to
the TCR and activates the p110d-isoform
of PI3K (Delgado et al., 2009), is upstream
of RhoG. Activated RhoG in turn promotes
actin polymerization, which is required
for trogocytosis (Figure 1).
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PreviewsAlthough the current view is that TCR
internalization dampens signaling by re-
moving the antigen and promoting re-
ceptor degradation, internalization of a
pMHC-TCR complex by trogocytosis
opens new questions. Is internalization
by trogocytosis a way to prolong the
TCR-pMHC interaction even after APC
separation? Are those TCRs still signaling
competent? In this regard, RhoG- or
TC21-deficient T cells stimulated by
APCs showed increased upregulation of
early TCR-mediated activation markers,
such as CD69. This could suggest that
signaling of TCRs from the cell surface
is required to stimulate TC21- and
RhoG-independent signaling cascades
that upregulate CD69. In contrast, T cell
proliferation was reduced in RhoG- or
TC21-deficient T cells, either suggesting
that trogocytosed TCRs are required to
stimulate proliferation or that RhoG and
TC21 are involved in the signaling path-
ways that promote proliferation.
Taken together, these data open novel
possibilities to study the functional conse-
quences of trogocytosis. Lineage-specific
deletion of RhoG could be useful to study
the contribution of trogocytosis in differ-
ent cell types in the course of immuneresponses, helping to characterize the
stimulatory or suppressive effects that
have been attributed to trogocytosis. T
helper cells that have captured pMHC via
trogocytosis can present these pMHC
complexes to other T cells, amplifying an
immune response. Cytotoxic T cells (CTLs)
that have captured agonistic pMHC by tro-
gocytosis become susceptible to cytolysis
by neighboring CTLs, which could result
in a dampening of an immune response.
While trying to understand the purpose
and consequences of trogocytosis, ener-
getic concerns arise: how do T cells
generate the force needed to tear off
the APC-membrane patch containing
pMHC?The force required topull a protein
and surrounding lipids from a membrane
is on the same order of magnitude as
the force needed to break a high-affinity
protein-protein interaction (Bell, 1978).
Therefore, trogocytosis could be energet-
ically beneficial for the T cell, given that
the acquired lipids could be recycled or
metabolized. This might increase the
capacity of the T cell to proliferate.
In that sense, T cells that are blood cells
themselves and take up protein com-
plexes in membrane ‘‘bites’’ from other
cells could be fancied as little vampiresImmunity 35that feed from their victims without killing
them.
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CD8+ dendritic cells comprise a distinct cell type whose function is unclear. In this issue of Immunity,
Mashayekhi et al. (2011) show these cells are essential for protection against the parasite Toxoplasma, but
Edelson et al. (2011) show they are hijacked by Listeria during initial spreading.Dendritic cells (DCs) are a distinct lineage
of mononuclear phagocytes that excel
at pathogen sensing, cytokine secretion,
and antigen presentation. The classical
DCs comprise two distinct subsets, dis-
tinguished in themouse by the expression
of CD8a (Shortman and Heath, 2010).
This subset dichotomy exists not only inlymphoid organs but also in tissues, in
which CD103+ DCs represent a genetic
and functional equivalent of CD8+ DCs.
Notably, CD8+ and CD103+ DCs are
found in relatively low numbers in vivo
(0.1%–0.2% of murine splenocytes), to
the dismay of researchers who study
them. A DC subset similar to CD8+ DCshas been identified in humans, with this
conservation probably reflecting an es-
sential role in immunity. An overwhelming
body of evidence suggests that CD8+
DCs are particularly efficient at cross-pre-
sentation, i.e., the presentation of exoge-
nously acquired antigens on MHC class I
molecules to CD8+ T cells. Although this, August 26, 2011 ª2011 Elsevier Inc. 153
